{"id":"W4400576900","doi":"10.1182/blood.2024024756","title":"Risk prediction for clonal cytopenia: multicenter real-world evidence","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Takeda Oncology; Center for Clinical and Translational Science, Mayo Clinic; Genentech; National Institutes of Health; Cancer Research UK; Alexion Pharmaceuticals; Apellis Pharmaceuticals; Sierra Oncology; Pfizer; Incyte; CTI Biopharma; TG Therapeutics; bluebird bio; Agios Pharmaceuticals; MEI Pharma; Eli Lilly and Company; Associazione Italiana per la Ricerca sul Cancro; Astex Pharmaceuticals; Acceleron; Edward P. Evans Foundation; Moffitt Cancer Center; National Cancer Institute; Gilead Sciences; Syndax Pharmaceuticals; BeiGene; MorphoSys; Celgene; AstraZeneca","keywords":"Cytopenia; Internal medicine; Cumulative incidence; Medicine; Proportional hazards model; Oncology; Cohort; Framingham Risk Score; Severe fever with thrombocytopenia syndrome; Incidence (geometry); Disease; Immunology; Bone marrow","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234514,0.0001223546,0.0001842464,0.0001785099,0.00008227129,0.00005787333,0.0001105313,0.00007782587,0.0001848745],"category_scores_gemma":[0.0004849431,0.0000979454,0.0001296712,0.0002799356,0.00005475902,0.0001770293,0.00006657132,0.0003886363,0.0002352462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001966652,"about_ca_system_score_gemma":0.0003169184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002341215,"about_ca_topic_score_gemma":0.00009159565,"domain_scores_codex":[0.9986925,0.0000465929,0.0002385567,0.0003738944,0.0003381004,0.0003103334],"domain_scores_gemma":[0.9989105,0.0004963718,0.00002995427,0.0002886288,0.0001243115,0.0001502069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003790025,0.001714488,0.5801424,0.003932501,0.002502694,0.001317906,0.001623568,0.00002410968,0.1053224,0.002316782,0.253567,0.04374617],"study_design_scores_gemma":[0.02099661,0.002871294,0.52069,0.004879936,0.004740976,0.0004601685,0.0001921821,0.06180074,0.09549063,0.0006474667,0.2865469,0.0006831319],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802782,0.00279691,0.002312019,0.004270345,0.0006823305,0.002333401,0.0003154038,0.0005230604,0.006488345],"genre_scores_gemma":[0.9798731,0.00127236,0.00476042,0.0001693176,0.001358216,0.0002464018,0.00005925082,0.00004935524,0.01221156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06177663,"threshold_uncertainty_score":0.3994097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03653534945482608,"score_gpt":0.3459327650009426,"score_spread":0.3093974155461165,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}